Sherilyn Junelle Recinto

Sherilyn Junelle Recinto

Auto-generated profile, based on publicly available information

Sherilyn Junelle Recinto

Montreal Neurological Institute-Hospital, McGill University

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 October 2024 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
ABArmin Bayati
Armin Bayati
RARiham Ayoubi
Riham Ayoubi
AAAdriana Aguila
Adriana Aguila
CZCornelia Emilia Zorca
Cornelia Emilia Zorca
GDGhislaine Deyab
Ghislaine Deyab
PMPeter S. McPherson
Peter S. McPherson

22 May 2025 in npj Parkinson's Disease
Verified
Journal Article
Open access
PDF file
SRSherilyn Junelle Recinto
Sherilyn Junelle Recinto
AKAlexandra Kazanova
Alexandra Kazanova
LLLin Liu
Lin Liu
BCBrendan Cordeiro
Brendan Cordeiro
SPShobina Premachandran
Shobina Premachandran
JSJo Anne Stratton
Jo Anne Stratton
Parkinson’s disease is characterized by a period of non-motor symptoms, including gastrointestinal dysfunction, preceding motor deficits by several years to decades. This long prodrome is suggestive of peripheral immunity involvement in the initiation of disease. We previously developed a model system in PINK1 KO mice displaying PD-like motor symptoms at late stages following intestinal infections. Herein, we map the initiating immune events at the site of infection in this model. Using single-cell RNAseq, we demonstrate that peripheral myeloid cells are the earliest highly dysregulated immune cell type followed by an aberrant T cell response shortly after. We also demonstrate an increased propensity for antigen presentation and that activated myeloid cells acquire a proinflammatory profile capable of inducing cytotoxic T cell responses. Together, our study provides the first evidence that PINK1 is a key regulator of immune functions in the gut underlying early PD-related disease mechanisms.

9 July 2024 in Journal of Biological Chemistry
Verified
Journal Article
Open access
YPYlauna Christine Mégane Penalva
Ylauna Christine Mégane Penalva
SPSandra Paschkowsky
Sandra Paschkowsky
SRSherilyn Junelle Recinto
Sherilyn Junelle Recinto
ADAnthony Duchesne
Anthony Duchesne
THThomas Hammond
Thomas Hammond
LMLisa Marie Munter
Lisa Marie Munter
The amyloid precursor protein (APP) is a key protein in Alzheimer's disease synthesized in the endoplasmic reticulum (ER) and translocated to the plasma membrane where it undergoes proteolytic cleavages by several proteases. Conversely, to other known proteases, we previously elucidated rhomboid protease RHBDL4 as a novel APP processing enzyme where several cleavages likely occur already in the ER. Interestingly, the pattern of RHBDL4-derived large APP C-terminal fragments resembles those generated by the η-secretase or MT5-MMP, which was described to generate so-called Aη fragments. The similarity in large APP C-terminal fragments between both proteases raised the question of whether RHBDL4 may contribute to η-secretase activity and Aη-like fragments. Here, we identified two cleavage sites of RHBDL4 in APP by mass spectrometry, which, intriguingly, lie in close proximity to the MT5-MMP cleavage sites. Indeed, we observed that RHBDL4 generates Aη-like fragments in vitro without contributions of α-, β-, or γ-secretases. Such Aη-like fragments are likely generated in the ER since RHBDL4-derived APP-C-terminal fragments do not reach the cell surface. Inherited, familial APP mutations appear to not affect this processing pathway. In RHBDL4 knockout mice, we observed increased cerebral full-length APP in comparison to wild type (WT) in support of RHBDL4 being a physiologically relevant protease for APP. Furthermore, we found secreted Aη fragments in dissociated mixed cortical cultures from WT mice, however significantly fewer Aη fragments in RHBDL4 knockout cultures. Our data underscores that RHBDL4 contributes to the η-secretease-like processing of APP and that RHBDL4 is a physiologically relevant protease for APP.

15 March 2024 in European Journal of Neuroscience
Verified
Journal Article
Open access
SRSherilyn Junelle Recinto
Sherilyn Junelle Recinto
SPShobina Premachandran
Shobina Premachandran
SMSriparna Mukherjee
Sriparna Mukherjee
AAAlexis Allot
Alexis Allot
AMAdam MacDonald
Adam MacDonald
JSJo Anne Stratton
Jo Anne Stratton
The enteric nervous system (ENS) comprises a complex network of neurons whereby a subset appears to be dopaminergic although the characteristics, roles, and implications in disease are less understood. Most investigations relating to enteric dopamine (DA) neurons rely on immunoreactivity to tyrosine hydroxylase (TH)—the rate‐limiting enzyme in the production of DA. However, TH immunoreactivity is likely to provide an incomplete picture. This study herein provides a comprehensive characterization of DA neurons in the gut using a reporter mouse line, expressing a fluorescent protein (tdTomato) under control of the DA transporter (DAT) promoter. Our findings confirm a unique localization of DA neurons in the gut and unveil the discrete subtypes of DA neurons in this organ, which we characterized using both immunofluorescence and single‐cell transcriptomics, as well as validated using in situ hybridization. We observed distinct subtypes of DAT‐tdTomato neurons expressing co‐transmitters and modulators across both plexuses; some of them likely co‐releasing acetylcholine, while others were positive for a slew of canonical DAergic markers (TH, VMAT2 and GIRK2). Interestingly, we uncovered a seemingly novel population of DA neurons unique to the ENS which was ChAT/DAT‐tdTomato‐immunoreactive and expressed Grp, Calcb, and Sst. Given the clear heterogeneity of DAergic gut neurons, further investigation is warranted to define their functional signatures and decipher their implication in disease.

26 February 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
AKAlexandra Kazanova
Alexandra Kazanova
JSJacqueline Sung
Jacqueline Sung
NONathalia Oliveira
Nathalia Oliveira
CGChristina Gavino
Christina Gavino
SRSherilyn Recinto
Sherilyn Recinto
SGSamantha Gruenheid
Samantha Gruenheid
Parkinson’s disease (PD) is a chronic neurodegenerative disorder characterized by progressive loss of motor function. Diagnosis occurs late: after motor symptom development downstream of the irreparable loss of a large proportion of the dopaminergic neurons in the substantia nigra of the brain. Understanding PD pathophysiology in its pre-motor prodromal phase is needed for earlier diagnosis and intervention. Genetic risk factors, environmental triggers, and dysregulated immunity have all been implicated in PD development. Here, we demonstrate in a mouse model deficient in the PD-associated gene Pink , that infection with the human PD-associated gastric bacterium Helicobacter pylori leads to development of motor and cognitive signs resembling prodromal features of PD. This was also associated with proliferation and activation of primary mitochondria-reactive CD8 T cells and infiltration of CD8 T cells into the brain. Development of the motor and cognitive phenotypes in the infected Pink1 −/− mice was abrogated when CD8 T cells were depleted prior to infection. We anticipate that this new model, which integrates genetic PD susceptibility, a PD-relevant environmental trigger, and specific immune changes that are required for symptom development, will be a valuable tool for increasing our understanding of this complex disease.

29 August 2025 in npj Parkinson's Disease
Verified
Journal Article
Open access
PDF file
JPJessica Pei
Jessica Pei
NONathalia L. Oliveira
Nathalia L. Oliveira
SRSherilyn J. Recinto
Sherilyn J. Recinto
AKAlexandra Kazanova
Alexandra Kazanova
CQCelso M. Queiroz-Junior
Celso M. Queiroz-Junior
SGSamantha Gruenheid
Samantha Gruenheid
Parkinson’s Disease (PD) is a neurodegenerative disorder often preceded by gastrointestinal dysfunction. Mutations in leucine-rich repeat kinase 2 ( LRRK2 ) are known risk factors for both PD and inflammatory bowel disease (IBD), suggesting a link between PD and the gastrointestinal tract. Using single-cell RNA-sequencing and spectral flow cytometry, we demonstrated that the Lrrk2 Gly2019Ser (G2019S) mutation is associated with an increased neutrophil presence in the colonic lamina propria during Citrobacter rodentium infection. This concurred with a Th17 skewing, upregulated Il17a , and greater colonic pathology during infection. In vitro experiments showed enhanced kinase-dependent neutrophil chemotaxis and neutrophil extracellular trap (NET) formation in Lrrk2 G2019S mice compared to wild-type counterparts. Our results add to the understanding of LRRK2-driven immune cell dysregulation and its contribution to PD, offering insights into potential biomarkers for early diagnosis and intervention in PD.